 |
市場調查報告書
商品編碼
2035254
微生物護膚市場預測至2034年－按產品類型、成分類型、肌膚問題、通路、最終用戶和地區分類的全球分析Microbiome Skincare Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Skin Concern, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 的數據，預計到 2026 年，全球微生物組護膚市場將達到 124 億美元，並在預測期內以 18.7% 的複合年成長率成長，到 2034 年達到 486 億美元。
微生物組護膚是指一類旨在支持、防曬油和身體保養皮膚天然微生物生態基材的化妝品和皮膚科產品，其透過維持皮膚微生物組的多樣性來實現這一目標。皮膚微生物組的多樣性與健康的屏障功能、減少發炎和增強對環境壓力的抵抗力密切相關。這類產品包括潔面乳、精華液、保濕霜、面膜、防曬乳、身體保養品和頭皮保養產品。它們通常含有益生菌菌株、益生元營養底物、後生元微生物代謝物、植物萃取物、酵素、發酵成分和生物活性胜肽。
皮膚微生物組科學的認可
消費者和皮膚科醫生對皮膚微生物群在屏障功能、發炎反應調節和慢性皮膚病管理中發揮的核心作用的認知迅速提高，這加速了以微生物群為靶點的護膚產品的普及。臨床證據表明，皮膚微生物群多樣性的紊亂與濕疹、痤瘡、酒糟和皮膚早衰密切相關，這促使大型企業和獨立品牌加大對益生菌和益生元護膚創新產品的投入，從而打造了一個具有科學依據的高階市場。
與益生菌穩定性相關的處方挑戰
在室溫儲存條件下，如何確保益生菌菌株在化妝品基質中整個保存期限內保持活性，是配方科學領域的根本性挑戰。這需要昂貴的包埋技術和厭氧包裝系統，從而顯著增加產品研發和生產成本。因此，這限制了微生物護膚品牌在高階專業美妝通路之外的普通零售通路的市場定位。
皮膚科醫生處方管道的成長
在皮膚科臨床實踐中，採用基於微生物組的護膚建議來治療濕疹、痤瘡、酒糟和脂漏性皮膚炎等慢性皮膚病，為高階專業管道帶來了機會。這促成了對高價值處方箋產品的推薦，這些產品具有醫療級的消費者信賴度，並且價格遠高於傳統護膚品，從而透過權威的臨床推薦管道，助力高階品牌實現銷售成長。
關於健康影響的監管限制
根據歐盟化妝品法規和美國食品藥物管理局（FDA）的藥品和化妝品分類框架，對含益生菌化妝品健康聲明的限制性規定，也限制了微生物組護膚品牌的行銷傳播。因此，必須在監管限制（例如提及特定皮膚問題的治療效果，這對於有效向注重健康的消費者傳達差異化的消費價值至關重要）與引人注目的消費者益處訊息。
新冠疫情的影響：
新冠疫情透過「口罩膝」（口罩引起的痤瘡）等症狀以及佩戴口罩對皮膚屏障功能的破壞，提高了人們對皮膚屏障健康的關注。這使得數百萬消費者透過皮膚科醫生在社群媒體上發布的關於「口罩膝」治療方法，開始了解皮膚微生物組科學。即使在疫情結束後，人們對最佳化皮膚健康以及免疫力與皮膚之間聯繫的持續關注，仍然極大地推動了全球消費者對洗面乳、精華液和保濕霜等支持微生物組的護膚產品的投資。
在預測期內，防曬油和防護產品細分市場預計將佔據最大的市場佔有率。
預計在預測期內，防曬油及防護產品細分市場將佔據最大的市場佔有率。這主要源自於市場對光防護和維持皮膚微生物群的雙重需求。傳統化學防曬油中的活性成分會透過其抗菌作用和對皮膚屏障功能的影響來破壞皮膚微生物群。而添加了益生元和益生元保護複合物的礦物防曬油，在阻擋紫外線的同時，還能支持有益的皮膚微生物群，滿足了消費者此前未被滿足的需求，並實現了較高的零售價格和購買頻率。
預計益生菌細分市場在預測期內將呈現最高的複合年成長率。
在預測期內，益生菌細分市場預計將呈現最高的成長率，這主要得益於越來越多的臨床證據表明，局部應用特定益生菌菌株可用於治療皮膚疾病，以及益生菌封裝和遞送技術的快速發展，使得活性菌培養物能夠被應用於更廣泛的化妝品產品中。消費者對特定益生菌作為成分的認知度不斷提高，推動了針對性護膚產品的購買，從而在微生物組成分類別中實現了最強勁的成長。
市佔率最大的地區：
在預測期內，北美預計將佔據最大的市場佔有率。這是因為美國擁有全球最發達的微生物護膚品牌生態系統，TULA Life、Mother Dirt 和 Gallinee 等先鋒品牌在國內市場取得了顯著的銷售表現。此外，皮膚科醫生推薦的廣泛認可提升了益生菌護膚的信譽度，消費者對科學驗證的高階護膚的投入也在不斷成長，這得益於眾多天然健康零售商和 D2C（直接面對消費者）數位管道的推動。
複合年成長率最高的地區：
在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要歸因於以下幾個因素：韓國和日本美容行業率先採用發酵成分和微生物組相關護膚技術，使該地區消費者對微生物組護膚理念產生了強烈的認同感；中國高階護膚市場快速成長，並加大對科學配方研發的投入；以及亞太地區本土微生物組護膚品牌的發展，充分利用該地區在發酵技術和植物成分方面的專業知識。
免費客製化服務：
所有購買此報告的客戶均可享受以下免費自訂選項之一：
- 企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
- 區域分類
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
- 競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。
目錄
第1章執行摘要
- 市場概覽及主要亮點
- 促進因素、挑戰和機遇
- 競爭格局概述
- 戰略洞察與建議
第2章：研究框架
- 研究目標和範圍
- 相關人員分析
- 研究假設和限制
- 調查方法
第3章 市場動態與趨勢分析
- 市場定義與結構
- 主要市場促進因素
- 市場限制與挑戰
- 投資成長機會和重點領域
- 產業威脅與風險評估
- 技術與創新展望
- 新興市場/高成長市場
- 監管和政策環境
- 新冠疫情的影響及復甦前景
第4章：競爭環境與策略評估
- 波特五力分析
- 供應商的議價能力
- 買方的議價能力
- 替代品的威脅
- 新進入者的威脅
- 競爭公司之間的競爭
- 主要公司市佔率分析
- 產品基準評效和效能比較
第5章：全球微生物組護膚市場：依產品類型分類
- 潔面乳/洗面乳
- 精華液和安瓿
- 保濕霜和乳霜
- 面膜治療
- 防曬油和防護產品
- 身體保養產品
- 頭皮和頭髮微生物群護理
第6章：全球微生物組護膚市場：依成分類型分類
- 益生菌
- 益生元
- 後生元
- 植物萃取物
- 酵素和發酵成分
- 胜肽和生物活性成分
第7章：全球微生物組護膚市場：依肌膚問題分類
- 痤瘡和皮膚問題
- 敏感肌膚
- 抗衰老和除皺
- 濕疹和皮膚炎
- 保濕和屏障功能修復
- 色素沉著
第8章：全球微生物組護膚市場：依通路分類
- 線上零售
- 專賣店
- 皮膚科診所
- 藥局/藥局
- 超級市場和大賣場
- 直接面對消費者 (D2C)
第9章：全球微生物組護膚市場：依最終用戶分類
- 女士
- 男性
- 青少年
- 嬰幼兒
- 皮膚科患者
第10章：全球微生物組護膚市場：依地區分類
- 北美洲
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
- 亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
- 南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
- 世界其他地區（RoW）
- 中東
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 以色列
- 其他中東國家
- 非洲
- 南非
- 埃及
- 摩洛哥
- 其他非洲國家
- 中東
第11章 策略市場資訊
- 工業價值網路和供應鏈評估
- 空白區域和機會地圖
- 產品演進與市場生命週期分析
- 通路、經銷商和打入市場策略的評估
第12章 產業趨勢與策略舉措
- 併購
- 夥伴關係、聯盟和合資企業
- 新產品發布和認證
- 擴大生產能力和投資
- 其他策略舉措
第13章：公司簡介
- L'Oreal SA
- Unilever PLC
- Procter & Gamble Co.
- Johnson & Johnson
- Estee Lauder Companies Inc.
- Shiseido Company Limited
- Beiersdorf AG
- Coty Inc.
- Pierre Fabre Group
- Gallinee Ltd.
- Mother Dirt（AOBiome）
- Esse Skincare
- TULA Life Inc.
- The Clorox Company（Burt's Bees）
- Colgate-Palmolive Company
- Amorepacific Corporation
- NAOS（Bioderma）
According to Stratistics MRC, the Global Microbiome Skincare Market is accounted for $12.4 billion in 2026 and is expected to reach $48.6 billion by 2034 growing at a CAGR of 18.7% during the forecast period. Microbiome skincare refers to a category of cosmetic and dermatological products including cleansers, serums, moisturizers, masks, sunscreens, body care, and scalp treatments formulated to support, balance, and restore the skin's resident microbial ecosystem by incorporating probiotic bacterial strains, prebiotic nutrient substrates, postbiotic microbial metabolites, botanical extracts, enzymes, ferments, and bioactive peptides that maintain the skin microbiome diversity associated with healthy barrier function, reduced inflammation, and resilience against environmental stressors.
Market Dynamics:
Driver:
Skin Microbiome Science Awareness
Rapidly expanding consumer and dermatologist awareness of the skin microbiome's central role in barrier function, inflammatory response regulation, and chronic skin condition management is driving accelerating adoption of microbiome-targeted skincare formulations. Clinical evidence linking disrupted skin microbiome diversity to eczema, acne, rosacea, and premature aging is generating substantial investment from both major conglomerates and indie brands in probiotic and prebiotic skincare innovation, creating a scientifically credible premium market segment.
Restraint:
Probiotic Stability Formulation Challenges
Maintaining viable probiotic bacterial strain stability within cosmetic product matrices across the full product shelf life at ambient storage conditions presents fundamental formulation science challenges that require expensive encapsulation technologies and anaerobic packaging systems, substantially increasing product development and manufacturing costs that limit accessible market positioning for microbiome skincare brands seeking mainstream retail distribution beyond premium specialty beauty channels.
Opportunity:
Dermatologist Prescription Channel Growth
Dermatology clinical practice adoption of microbiome skincare recommendations for chronic skin condition management including eczema, acne, rosacea, and seborrheic dermatitis represents a premium professional channel opportunity generating high-value prescription-adjacent product recommendations that command healthcare-level consumer confidence and price premium justification substantially above conventional skincare positioning, enabling premium brand revenue growth through authoritative clinical endorsement channels.
Threat:
Regulatory Health Claim Restrictions
Regulatory restrictions limiting permissible health benefit claims for probiotic-containing cosmetic products under EU cosmetics regulation and FDA drug-cosmetic distinction frameworks constrain microbiome skincare brand marketing communications, requiring careful navigation between compelling consumer benefit messaging and regulatory claim boundaries that limit ability to reference specific skin condition treatment outcomes that would most effectively communicate differentiated consumer value to health-motivated purchasing audiences.
Covid-19 Impact:
COVID-19 elevated awareness of skin barrier health as mask-wearing generated mask-related acne and barrier disruption experiences that introduced millions of consumers to skin microbiome science through dermatologist social media content addressing maskne treatment. Post-pandemic sustained interest in skin health optimization and immune-skin connection research continues generating strong consumer investment in microbiome-supporting skincare formulations across cleansers, serums, and moisturizer categories globally.
The sunscreen & protection products segment is expected to be the largest during the forecast period
The sunscreen & protection products segment is expected to account for the largest market share during the forecast period, due to the dual market demand for photoprotection combined with skin microbiome preservation that conventional chemical sunscreen active ingredients disrupt through antimicrobial and barrier-altering effects. Mineral sunscreen formulations incorporating prebiotic and postbiotic protective complexes that simultaneously protect against UV radiation while supporting beneficial skin microbial populations address an unmet consumer need commanding premium retail positioning and strong purchase frequency.
The probiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the probiotics segment is predicted to witness the highest growth rate, driven by expanding clinical evidence for specific probiotic strain topical application in skin condition management combined with rapid advancement in probiotic encapsulation and delivery technology enabling viable live bacterial culture incorporation in a broader range of cosmetic product formats. Consumer ingredient awareness of specific probiotic species driving targeted skincare purchasing is generating the strongest growth within the microbiome ingredient category.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most developed microbiome skincare brand ecosystem with pioneers including TULA Life, Mother Dirt, and Gallinee generating substantial domestic revenue, strong dermatology professional endorsement culture amplifying probiotic skincare credibility, and high consumer investment in science-backed premium skincare supported by extensive natural health retail and direct-to-consumer digital channels.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to South Korean and Japanese beauty industries pioneering fermented ingredient and microbiome-adjacent skincare technology generating strong regional consumer familiarity with microbiome skincare concepts, rapidly growing Chinese premium skincare market investing in science-backed formulations, and expanding domestic microbiome skincare brand development across Asia Pacific leveraging regional fermentation and botanical ingredient expertise.
Key players in the market
Some of the key players in Microbiome Skincare Market include L'Oreal S.A., Unilever PLC, Procter & Gamble Co., Johnson & Johnson, Estee Lauder Companies Inc., Shiseido Company Limited, Beiersdorf AG, Coty Inc., Pierre Fabre Group, Gallinee Ltd., Mother Dirt (AOBiome), Esse Skincare, TULA Life Inc., The Clorox Company (Burt's Bees), Colgate-Palmolive Company, Amorepacific Corporation, and NAOS (Bioderma).
Key Developments:
In March 2026, L'Oreal S.A. launched its Vichy Probiotic Serum range incorporating clinically validated Lactobacillus lysate postbiotics demonstrating significant skin barrier reinforcement and microbiome diversity improvement in consumer trials.
In January 2026, TULA Life Inc. expanded its probiotic skincare platform with a new microbiome-targeted SPF range combining mineral sun protection with prebiotic complex preserving beneficial skin bacterial diversity during UV exposure.
In December 2025, Gallinee Ltd. secured major European pharmacy distribution expansion for its microbiome facial care range following publication of independent clinical study confirming significant skin microbiome diversity improvement after 12-week use.
In November 2025, NAOS (Bioderma) introduced an Atoderm microbiome-restoring body lotion with patented postbiotic complex for eczema-prone skin achieving European dermatology association endorsement and pharmacy channel recommendation programs.
Product Types Covered:
- Cleansers & Face Wash
- Serums & Ampoules
- Moisturizers & Creams
- Masks & Treatments
- Sunscreen & Protection Products
- Body Care Products
- Scalp & Hair Microbiome Care
Ingredient Types Covered:
- Probiotics
- Prebiotics
- Postbiotics
- Botanical Extracts
- Enzymes & Ferments
- Peptides & Bioactives
Skin Concerns Covered:
- Acne & Blemishes
- Sensitive Skin
- Anti-Aging & Wrinkles
- Eczema & Dermatitis
- Hydration & Barrier Repair
- Hyperpigmentation
Distribution Channels Covered:
- Online Retail
- Specialty Stores
- Dermatology Clinics
- Pharmacies & Drugstores
- Supermarkets & Hypermarkets
- Direct-to-Consumer (D2C)
End Users Covered:
- Women
- Men
- Teenagers
- Infants & Kids
- Dermatology Patients
Regions Covered:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
- Rest of the World (RoW)
- Middle East
- Saudi Arabia
- United Arab Emirates
- Qatar
- Israel
- Rest of Middle East
- Africa
- South Africa
- Egypt
- Morocco
- Rest of Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
- 1.1 Market Snapshot and Key Highlights
- 1.2 Growth Drivers, Challenges, and Opportunities
- 1.3 Competitive Landscape Overview
- 1.4 Strategic Insights and Recommendations
2 Research Framework
- 2.1 Study Objectives and Scope
- 2.2 Stakeholder Analysis
- 2.3 Research Assumptions and Limitations
- 2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
- 3.1 Market Definition and Structure
- 3.2 Key Market Drivers
- 3.3 Market Restraints and Challenges
- 3.4 Growth Opportunities and Investment Hotspots
- 3.5 Industry Threats and Risk Assessment
- 3.6 Technology and Innovation Landscape
- 3.7 Emerging and High-Growth Markets
- 3.8 Regulatory and Policy Environment
- 3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
- 4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
- 4.2 Market Share Analysis of Key Players
- 4.3 Product Benchmarking and Performance Comparison
5 Global Microbiome Skincare Market, By Product Type
- 5.1 Cleansers & Face Wash
- 5.2 Serums & Ampoules
- 5.3 Moisturizers & Creams
- 5.4 Masks & Treatments
- 5.5 Sunscreen & Protection Products
- 5.6 Body Care Products
- 5.7 Scalp & Hair Microbiome Care
6 Global Microbiome Skincare Market, By Ingredient Type
- 6.1 Probiotics
- 6.2 Prebiotics
- 6.3 Postbiotics
- 6.4 Botanical Extracts
- 6.5 Enzymes & Ferments
- 6.6 Peptides & Bioactives
7 Global Microbiome Skincare Market, By Skin Concern
- 7.1 Acne & Blemishes
- 7.2 Sensitive Skin
- 7.3 Anti-Aging & Wrinkles
- 7.4 Eczema & Dermatitis
- 7.5 Hydration & Barrier Repair
- 7.6 Hyperpigmentation
8 Global Microbiome Skincare Market, By Distribution Channel
- 8.1 Online Retail
- 8.2 Specialty Stores
- 8.3 Dermatology Clinics
- 8.4 Pharmacies & Drugstores
- 8.5 Supermarkets & Hypermarkets
- 8.6 Direct-to-Consumer (D2C)
9 Global Microbiome Skincare Market, By End User
- 9.1 Women
- 9.2 Men
- 9.3 Teenagers
- 9.4 Infants & Kids
- 9.5 Dermatology Patients
10 Global Microbiome Skincare Market, By Geography
- 10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
- 10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
- 10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
- 10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
- 10.5 Rest of the World (RoW)
- 10.5.1 Middle East
- 10.5.1.1 Saudi Arabia
- 10.5.1.2 United Arab Emirates
- 10.5.1.3 Qatar
- 10.5.1.4 Israel
- 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
- 10.5.2.1 South Africa
- 10.5.2.2 Egypt
- 10.5.2.3 Morocco
- 10.5.2.4 Rest of Africa
- 10.5.1 Middle East
11 Strategic Market Intelligence
- 11.1 Industry Value Network and Supply Chain Assessment
- 11.2 White-Space and Opportunity Mapping
- 11.3 Product Evolution and Market Life Cycle Analysis
- 11.4 Channel, Distributor, and Go-to-Market Assessment
12 Industry Developments and Strategic Initiatives
- 12.1 Mergers and Acquisitions
- 12.2 Partnerships, Alliances, and Joint Ventures
- 12.3 New Product Launches and Certifications
- 12.4 Capacity Expansion and Investments
- 12.5 Other Strategic Initiatives
13 Company Profiles
- 13.1 L'Oreal S.A.
- 13.2 Unilever PLC
- 13.3 Procter & Gamble Co.
- 13.4 Johnson & Johnson
- 13.5 Estee Lauder Companies Inc.
- 13.6 Shiseido Company Limited
- 13.7 Beiersdorf AG
- 13.8 Coty Inc.
- 13.9 Pierre Fabre Group
- 13.10 Gallinee Ltd.
- 13.11 Mother Dirt (AOBiome)
- 13.12 Esse Skincare
- 13.13 TULA Life Inc.
- 13.14 The Clorox Company (Burt's Bees)
- 13.15 Colgate-Palmolive Company
- 13.16 Amorepacific Corporation
- 13.17 NAOS (Bioderma)
List of Tables
- Table 1 Global Microbiome Skincare Market Outlook, By Region (2023-2034) ($MN)
- Table 2 Global Microbiome Skincare Market Outlook, By Product Type (2023-2034) ($MN)
- Table 3 Global Microbiome Skincare Market Outlook, By Cleansers & Face Wash (2023-2034) ($MN)
- Table 4 Global Microbiome Skincare Market Outlook, By Serums & Ampoules (2023-2034) ($MN)
- Table 5 Global Microbiome Skincare Market Outlook, By Moisturizers & Creams (2023-2034) ($MN)
- Table 6 Global Microbiome Skincare Market Outlook, By Masks & Treatments (2023-2034) ($MN)
- Table 7 Global Microbiome Skincare Market Outlook, By Sunscreen & Protection Products (2023-2034) ($MN)
- Table 8 Global Microbiome Skincare Market Outlook, By Body Care Products (2023-2034) ($MN)
- Table 9 Global Microbiome Skincare Market Outlook, By Scalp & Hair Microbiome Care (2023-2034) ($MN)
- Table 10 Global Microbiome Skincare Market Outlook, By Ingredient Type (2023-2034) ($MN)
- Table 11 Global Microbiome Skincare Market Outlook, By Probiotics (2023-2034) ($MN)
- Table 12 Global Microbiome Skincare Market Outlook, By Prebiotics (2023-2034) ($MN)
- Table 13 Global Microbiome Skincare Market Outlook, By Postbiotics (2023-2034) ($MN)
- Table 14 Global Microbiome Skincare Market Outlook, By Botanical Extracts (2023-2034) ($MN)
- Table 15 Global Microbiome Skincare Market Outlook, By Enzymes & Ferments (2023-2034) ($MN)
- Table 16 Global Microbiome Skincare Market Outlook, By Peptides & Bioactives (2023-2034) ($MN)
- Table 17 Global Microbiome Skincare Market Outlook, By Skin Concern (2023-2034) ($MN)
- Table 18 Global Microbiome Skincare Market Outlook, By Acne & Blemishes (2023-2034) ($MN)
- Table 19 Global Microbiome Skincare Market Outlook, By Sensitive Skin (2023-2034) ($MN)
- Table 20 Global Microbiome Skincare Market Outlook, By Anti-Aging & Wrinkles (2023-2034) ($MN)
- Table 21 Global Microbiome Skincare Market Outlook, By Eczema & Dermatitis (2023-2034) ($MN)
- Table 22 Global Microbiome Skincare Market Outlook, By Hydration & Barrier Repair (2023-2034) ($MN)
- Table 23 Global Microbiome Skincare Market Outlook, By Hyperpigmentation (2023-2034) ($MN)
- Table 24 Global Microbiome Skincare Market Outlook, By Distribution Channel (2023-2034) ($MN)
- Table 25 Global Microbiome Skincare Market Outlook, By Online Retail (2023-2034) ($MN)
- Table 26 Global Microbiome Skincare Market Outlook, By Specialty Stores (2023-2034) ($MN)
- Table 27 Global Microbiome Skincare Market Outlook, By Dermatology Clinics (2023-2034) ($MN)
- Table 28 Global Microbiome Skincare Market Outlook, By Pharmacies & Drugstores (2023-2034) ($MN)
- Table 29 Global Microbiome Skincare Market Outlook, By Supermarkets & Hypermarkets (2023-2034) ($MN)
- Table 30 Global Microbiome Skincare Market Outlook, By Direct-to-Consumer (D2C) (2023-2034) ($MN)
- Table 31 Global Microbiome Skincare Market Outlook, By End User (2023-2034) ($MN)
- Table 32 Global Microbiome Skincare Market Outlook, By Women (2023-2034) ($MN)
- Table 33 Global Microbiome Skincare Market Outlook, By Men (2023-2034) ($MN)
- Table 34 Global Microbiome Skincare Market Outlook, By Teenagers (2023-2034) ($MN)
- Table 35 Global Microbiome Skincare Market Outlook, By Infants & Kids (2023-2034) ($MN)
- Table 36 Global Microbiome Skincare Market Outlook, By Dermatology Patients (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
